Gene studies point to a potential treatment for the aggressive brain tumour glioblastoma that spares normal cells
This is a deadly glioblastoma brain tumour, seen down a microscope and stained to reveal living (purple) and dying (red) cancer cells. Scientists have long been struggling to understand what makes these cancers so difficult to treat and the search has now led to a gene called TERT, which is the most commonly altered gene in glioblastoma. TERT is an important component of telomerase – the molecular ‘immortality machine’ that maintains DNA so cancer cells can keep dividing. Unfortunately, TERT is also needed by healthy cells so it's hard to target with anti-cancer drugs. But researchers have now found that TERT is activated by another molecule, GABP-beta1L, which isn’t needed by healthy cells but is essential for making cancer cells immortal. Getting rid of GABP-beta1L dramatically slows down the growth of glioblastoma cells in the lab – an approach that could be developed into a potentially powerful treatment in the future.
Written by Kat Arney
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.